Doctor profile · Federal record
Dr. Lodewyk Papenfus, M.D.
Family Medicine Physician (CMS: Family Practice) · Scottsbluff, NE
- NPI 1841205424
- Accepts Medicare
- MIPS 77.0 / 100 · 2023
- 39 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3911 Avenue B, Suite 1100
Scottsbluff, NE 693614617
(308) 630-2100
fax (308) 630-2113 - Mailing address
-
1002 Mockingbird Dr
Scottsbluff, NE 693614923
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- February 10, 2014
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207Q00000X — NUCC code
- State license (1)
- Nebraska #21968
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1841205424. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,769
Distinct HCPCS
10
Medicare allowed
$270,412
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 4,920 | 46 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 957 | 488 | $118 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 259 | 83 | $6 | |
17000 |
Destruction of precancer skin growth, 1 growth | 129 | 95 | $59 | |
96372 |
Injection of drug or substance under skin or into muscle | 101 | 51 | $13 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 97 | 91 | $83 | |
90694 |
Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 65 | 63 | $75 | |
G0008 |
Administration of influenza virus vaccine | 64 | 62 | $19 | |
G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 31 | 31 | $112 | |
71046 |
X-ray of chest, 2 views | 27 | 20 | $24 |
In context: peer comparison
Among 3 peers in Scottsbluff Family Medicine Physician, average services per provider: 236. This provider delivers 29× the peer median.Open Payments
Industry payments received
All-time total
$254
Transactions
12
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 5 | $116.56 | |
| Otsuka America Pharmaceutical, INC. | 1 | $25.61 | |
| Novartis Pharmaceuticals Corporation | 1 | $24.68 | |
| Phathom Pharmaceuticals, INC. | 1 | $21.56 | |
| Abbott Laboratories | 1 | $18.56 | |
| Merck Sharp & Dohme LLC | 1 | $16.49 | |
| Mylan Specialty L.P. | 1 | $16.31 | |
| Amgen INC. | 1 | $14.08 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
5,144
Patients
1,228
Total drug cost
$254,899
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Losartan Potassium | Generic | 850 | 211 | $10,426 |
| Levothyroxine Sodium | Generic | 598 | 113 | $5,980 |
| Atorvastatin Calcium | Generic | 462 | 119 | $5,750 |
| Rosuvastatin Calcium | Generic | 457 | 129 | $8,905 |
| Amlodipine Besylate | Generic | 394 | 88 | $4,329 |
| Pantoprazole Sodium | Generic | 314 | 79 | $4,683 |
| Eliquis (Apixaban) | Brand | 302 | 40 | $194,375 |
| Metformin Hcl ER (Metformin Hcl) | Brand | 289 | 87 | $2,767 |
| Hydrochlorothiazide | Generic | 273 | 78 | $1,756 |
| Montelukast Sodium | Generic | 271 | 84 | $3,456 |
Hospital affiliations
Frequently asked questions
What is Dr. Lodewyk Papenfus's medical specialty?
Dr. Lodewyk Papenfus practices Family Medicine Physician in Scottsbluff, NE.
Where does Dr. Lodewyk Papenfus practice?
Dr. Lodewyk Papenfus practices at 3911 Avenue B, Scottsbluff, NE 693614617. Office phone: 3086302100.
What is Dr. Lodewyk Papenfus's NPI?
Dr. Lodewyk Papenfus's National Provider Identifier (NPI) is 1841205424, issued by NPPES.
Does Dr. Lodewyk Papenfus accept Medicare assignment?
Yes. Dr. Lodewyk Papenfus accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lodewyk Papenfus commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.